Message Font: Serif | Sans-Serif
 
No. of Recommendations: 2

Hi, my first post to the Biotech board!

My husband has diabetes, so this has been of interest to me for some time.

Earnings: Feb 28

Obviously this has been a little slow getting off the ground; I think Pfizer is finally starting marketing this year.

Elsewhere, someone mentioned a potential competitor coming out?

This is from a recent Forbes article: http://www.forbes.com/feeds/ap/2007/01/23/ap3353388.html
Exubera is an inhalable insulin that uses drug-delivery technology made by Nektar. Pfizer (nyse: PFE - news - people ) is selling the drug and did not disclose sales results for Exubera with its earnings figures Monday. It said it is initiating a strong marketing campaign to primary care doctors and will launch a direct-to-consumer campaign later in the year.

Any comments, complaints, suggestions, etc - very welcome.

Sarah

Sarah
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Community Home
Speak Your Mind, Start Your Blog, Rate Your Stocks

Community Team Fools - who are those TMF's?
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.
Advertisement